The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inhaler Devices Market Research Report 2025
Synopsis
Inhaler devices are used to deliver a variety of inhaled medications, including beta-agonists, anticholinergics, glucocorticoids, tobramycin, and insulin. Three main types of inhaler devices are available: the pressurized metered dose inhaler (MDI), the dry powder inhaler (DPI), and the soft mist inhaler (SMI).
The global Inhaler Devices market was valued at US$ 542 million in 2023 and is anticipated to reach US$ 812.7 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
North American market for Inhaler Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inhaler Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Inhaler Devices include 3M, Bespak, Gerresheimer AG, Hovione, Iconovo AB, Adherium, Cohero Health, Trudell Medical International and Beximco Pharmaceuticals Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inhaler Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaler Devices.
Report Scope
The Inhaler Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaler Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaler Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Bespak
Gerresheimer AG
Hovione
Iconovo AB
Adherium
Cohero Health
Trudell Medical International
Beximco Pharmaceuticals Ltd
Boehringer Ingelheim GmbH
Cipla Ltd
GSK
PARI Medical Holding
Teva Pharmaceutical Industries Ltd
Segment by Type
Metered Dose Inhaler (MDI)
Dry Powder Inhaler (DPI)
Soft Mist Inhaler (SMI)
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaler Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaler Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Inhaler devices are used to deliver a variety of inhaled medications, including beta-agonists, anticholinergics, glucocorticoids, tobramycin, and insulin. Three main types of inhaler devices are available: the pressurized metered dose inhaler (MDI), the dry powder inhaler (DPI), and the soft mist inhaler (SMI).
The global Inhaler Devices market was valued at US$ 542 million in 2023 and is anticipated to reach US$ 812.7 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
North American market for Inhaler Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inhaler Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Inhaler Devices include 3M, Bespak, Gerresheimer AG, Hovione, Iconovo AB, Adherium, Cohero Health, Trudell Medical International and Beximco Pharmaceuticals Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inhaler Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaler Devices.
Report Scope
The Inhaler Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaler Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaler Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Bespak
Gerresheimer AG
Hovione
Iconovo AB
Adherium
Cohero Health
Trudell Medical International
Beximco Pharmaceuticals Ltd
Boehringer Ingelheim GmbH
Cipla Ltd
GSK
PARI Medical Holding
Teva Pharmaceutical Industries Ltd
Segment by Type
Metered Dose Inhaler (MDI)
Dry Powder Inhaler (DPI)
Soft Mist Inhaler (SMI)
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaler Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaler Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Inhaler Devices Market Overview
1.1 Product Overview and Scope of Inhaler Devices
1.2 Inhaler Devices Segment by Type
1.2.1 Global Inhaler Devices Market Value Comparison by Type (2024-2030)
1.2.2 Metered Dose Inhaler (MDI)
1.2.3 Dry Powder Inhaler (DPI)
1.2.4 Soft Mist Inhaler (SMI)
1.3 Inhaler Devices Segment by Application
1.3.1 Global Inhaler Devices Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Inhaler Devices Market Size Estimates and Forecasts
1.4.1 Global Inhaler Devices Revenue 2019-2030
1.4.2 Global Inhaler Devices Sales 2019-2030
1.4.3 Global Inhaler Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inhaler Devices Market Competition by Manufacturers
2.1 Global Inhaler Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inhaler Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inhaler Devices Average Price by Manufacturers (2019-2024)
2.4 Global Inhaler Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhaler Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhaler Devices, Product Type & Application
2.7 Inhaler Devices Market Competitive Situation and Trends
2.7.1 Inhaler Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhaler Devices Players Market Share by Revenue
2.7.3 Global Inhaler Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhaler Devices Retrospective Market Scenario by Region
3.1 Global Inhaler Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inhaler Devices Global Inhaler Devices Sales by Region: 2019-2030
3.2.1 Global Inhaler Devices Sales by Region: 2019-2024
3.2.2 Global Inhaler Devices Sales by Region: 2025-2030
3.3 Global Inhaler Devices Global Inhaler Devices Revenue by Region: 2019-2030
3.3.1 Global Inhaler Devices Revenue by Region: 2019-2024
3.3.2 Global Inhaler Devices Revenue by Region: 2025-2030
3.4 North America Inhaler Devices Market Facts & Figures by Country
3.4.1 North America Inhaler Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inhaler Devices Sales by Country (2019-2030)
3.4.3 North America Inhaler Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inhaler Devices Market Facts & Figures by Country
3.5.1 Europe Inhaler Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inhaler Devices Sales by Country (2019-2030)
3.5.3 Europe Inhaler Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhaler Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Inhaler Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inhaler Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Inhaler Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inhaler Devices Market Facts & Figures by Country
3.7.1 Latin America Inhaler Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inhaler Devices Sales by Country (2019-2030)
3.7.3 Latin America Inhaler Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhaler Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaler Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inhaler Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inhaler Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhaler Devices Sales by Type (2019-2030)
4.1.1 Global Inhaler Devices Sales by Type (2019-2024)
4.1.2 Global Inhaler Devices Sales by Type (2025-2030)
4.1.3 Global Inhaler Devices Sales Market Share by Type (2019-2030)
4.2 Global Inhaler Devices Revenue by Type (2019-2030)
4.2.1 Global Inhaler Devices Revenue by Type (2019-2024)
4.2.2 Global Inhaler Devices Revenue by Type (2025-2030)
4.2.3 Global Inhaler Devices Revenue Market Share by Type (2019-2030)
4.3 Global Inhaler Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inhaler Devices Sales by Application (2019-2030)
5.1.1 Global Inhaler Devices Sales by Application (2019-2024)
5.1.2 Global Inhaler Devices Sales by Application (2025-2030)
5.1.3 Global Inhaler Devices Sales Market Share by Application (2019-2030)
5.2 Global Inhaler Devices Revenue by Application (2019-2030)
5.2.1 Global Inhaler Devices Revenue by Application (2019-2024)
5.2.2 Global Inhaler Devices Revenue by Application (2025-2030)
5.2.3 Global Inhaler Devices Revenue Market Share by Application (2019-2030)
5.3 Global Inhaler Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 3M Inhaler Devices Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Bespak
6.2.1 Bespak Corporation Information
6.2.2 Bespak Description and Business Overview
6.2.3 Bespak Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bespak Inhaler Devices Product Portfolio
6.2.5 Bespak Recent Developments/Updates
6.3 Gerresheimer AG
6.3.1 Gerresheimer AG Corporation Information
6.3.2 Gerresheimer AG Description and Business Overview
6.3.3 Gerresheimer AG Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Gerresheimer AG Inhaler Devices Product Portfolio
6.3.5 Gerresheimer AG Recent Developments/Updates
6.4 Hovione
6.4.1 Hovione Corporation Information
6.4.2 Hovione Description and Business Overview
6.4.3 Hovione Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hovione Inhaler Devices Product Portfolio
6.4.5 Hovione Recent Developments/Updates
6.5 Iconovo AB
6.5.1 Iconovo AB Corporation Information
6.5.2 Iconovo AB Description and Business Overview
6.5.3 Iconovo AB Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Iconovo AB Inhaler Devices Product Portfolio
6.5.5 Iconovo AB Recent Developments/Updates
6.6 Adherium
6.6.1 Adherium Corporation Information
6.6.2 Adherium Description and Business Overview
6.6.3 Adherium Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Adherium Inhaler Devices Product Portfolio
6.6.5 Adherium Recent Developments/Updates
6.7 Cohero Health
6.6.1 Cohero Health Corporation Information
6.6.2 Cohero Health Description and Business Overview
6.6.3 Cohero Health Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cohero Health Inhaler Devices Product Portfolio
6.7.5 Cohero Health Recent Developments/Updates
6.8 Trudell Medical International
6.8.1 Trudell Medical International Corporation Information
6.8.2 Trudell Medical International Description and Business Overview
6.8.3 Trudell Medical International Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Trudell Medical International Inhaler Devices Product Portfolio
6.8.5 Trudell Medical International Recent Developments/Updates
6.9 Beximco Pharmaceuticals Ltd
6.9.1 Beximco Pharmaceuticals Ltd Corporation Information
6.9.2 Beximco Pharmaceuticals Ltd Description and Business Overview
6.9.3 Beximco Pharmaceuticals Ltd Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beximco Pharmaceuticals Ltd Inhaler Devices Product Portfolio
6.9.5 Beximco Pharmaceuticals Ltd Recent Developments/Updates
6.10 Boehringer Ingelheim GmbH
6.10.1 Boehringer Ingelheim GmbH Corporation Information
6.10.2 Boehringer Ingelheim GmbH Description and Business Overview
6.10.3 Boehringer Ingelheim GmbH Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boehringer Ingelheim GmbH Inhaler Devices Product Portfolio
6.10.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.11 Cipla Ltd
6.11.1 Cipla Ltd Corporation Information
6.11.2 Cipla Ltd Inhaler Devices Description and Business Overview
6.11.3 Cipla Ltd Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cipla Ltd Inhaler Devices Product Portfolio
6.11.5 Cipla Ltd Recent Developments/Updates
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Inhaler Devices Description and Business Overview
6.12.3 GSK Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 GSK Inhaler Devices Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 PARI Medical Holding
6.13.1 PARI Medical Holding Corporation Information
6.13.2 PARI Medical Holding Inhaler Devices Description and Business Overview
6.13.3 PARI Medical Holding Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 PARI Medical Holding Inhaler Devices Product Portfolio
6.13.5 PARI Medical Holding Recent Developments/Updates
6.14 Teva Pharmaceutical Industries Ltd
6.14.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.14.2 Teva Pharmaceutical Industries Ltd Inhaler Devices Description and Business Overview
6.14.3 Teva Pharmaceutical Industries Ltd Inhaler Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Teva Pharmaceutical Industries Ltd Inhaler Devices Product Portfolio
6.14.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaler Devices Industry Chain Analysis
7.2 Inhaler Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaler Devices Production Mode & Process
7.4 Inhaler Devices Sales and Marketing
7.4.1 Inhaler Devices Sales Channels
7.4.2 Inhaler Devices Distributors
7.5 Inhaler Devices Customers
8 Inhaler Devices Market Dynamics
8.1 Inhaler Devices Industry Trends
8.2 Inhaler Devices Market Drivers
8.3 Inhaler Devices Market Challenges
8.4 Inhaler Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
